Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Sep 20, 2022 10:10pm
284 Views
Post# 34975374

RE:RE:RE:RE:RE:RE:RE:Weak hands -

RE:RE:RE:RE:RE:RE:RE:Weak hands -Prof. McFarland's job (creating the molecule that we are dealing with in the current clinical trial) ended in 2011 when she delivered the molecule to Theralase.

From there on, everything that needed to be done (in-vivo, in-vitro, preclinical tests (on rats and then on beagles), clinical trials, Dr. Rueck's expertise, TLC-3000, etc ...) to make sure this molecule doesn't lose any of its amazing attributes has been done by TLT, with the assistance of UHN.

Considering the revenues at play and the competition, it's absolutely not abnormal that we don't have more transparency than what you would expect.  The MD&A gives enough for us to know the priorities and the rest is about execution and there are things that are under the control of TLT.  

The rest is about waiting, whether you have 1000 shares or 1M shares.  It doesn't justify that more be disclosed because one owns more than others.

Anyways, not one agree on what they would like to be disclosed.  And many don't even master the field of expertise that TLT is involved in.  So management so far as done a great job given that they adjusted to all obstacles so far and that we are 3-months away from applying for Breakthrough designation and that we captured the attention of NML.  Not bad.  Not bad at all.


_________________


RE:RE:RE:RE:RE:RE:Weak hands -

I did make those purchases and i am not sure i feel what i said more more than my truthful opinion. I still have high hopes for TLT, and have proven that by continously investing. All you do is bash anyone w an opinion other than yours and can't look at things objectively, whether it be the present issues or past. I don't need you to believe me or my posts, put me on ignore or bash everything I say, but this site is meant for us to voice our opinions, not be sheep. Yes, I was disappointed in the last NR and several others, but I do have a good relationship with mcfarland and combs, so sometimes i need to look past my frustration with management. BUT, i would hate to see a PP done at such low levels, I know you claim that it isn't going to happen, but the company did reference it in one of their statements in the last few months. It is september 20, possibly less than 90 days from supposed BTD, do you have any reasoning thant would justify at 25c stock price?
RE:RE:RE:RE:RE:RE:Weak hands -

I did make those purchases and i am not sure i feel what i said more more than my truthful opinion. I still have high hopes for TLT, and have proven that by continously investing. All you do is bash anyone w an opinion other than yours and can't look at things objectively, whether it be the present issues or past. I don't need you to believe me or my posts, put me on ignore or bash everything I say, but this site is meant for us to voice our opinions, not be sheep. Yes, I was disappointed in the last NR and several others, but I do have a good relationship with mcfarland and combs, so sometimes i need to look past my frustration with management. BUT, i would hate to see a PP done at such low levels, I know you claim that it isn't going to happen, but the company did reference it in one of their statements in the last few months. It is september 20, possibly less than 90 days from supposed BTD, do you have any reasoning thant would justify at 25c stock price?
<< Previous
Bullboard Posts
Next >>